Macquarie Asset Management released its Q2 2025 investor letter, citing government policy changes and geopolitical events. The Fund’s Institutional Class shares had a 11.24% return but underperformed the benchmark Russell 1000 Growth Index at 17.84%. Top picks included UnitedHealth Group, with a 10.44% one-month return and $304.931 billion market cap.

The letter highlighted UnitedHealth Group as a top stock and noted challenges faced by the company, such as coding issues affecting reimbursement. Despite headwinds, the company remains a healthcare powerhouse in the US. UnitedHealth Group is 18th among the 30 most popular stocks among hedge funds, with 159 portfolios holding shares in Q2 2025.

With $112 billion in revenues in Q2 2025, UnitedHealth Group saw a 13% increase from the previous year. While recognized as a solid investment, some believe AI stocks offer greater potential. An undervalued AI stock with benefits from Trump-era tariffs and onshoring trend is recommended for investors seeking significant growth.

Read more at Yahoo Finance: Multiple Challenges Hit UnitedHealth Group (UNH) in Q2